Vol 16, No 2 (2022)
Research paper
Published online: 2022-03-29

open access

Page views 4829
Article views/downloads 466
Get Citation

Connect on Social Media

Connect on Social Media

The use of complementary and alternative therapy by advanced cancer patients receiving palliative care at home

Łukasz Pietrzyński1, Dariusz Pysz-Waberski1, Tatiana Pietrzyńska2, Michał Kliber1, Iwona Gisterek1
Palliat Med Pract 2022;16(2):108-116.

Abstract

Introduction: The purpose of this study was to evaluate the use of complementary and alternative
therapies (CAT) by palliative care patients treated at home in Poland.
Patients and methods: A total of 241 adult patients with advanced or metastatic cancer who were
qualified for palliative care provided at home filled out the CAT screening tool. Data were analysed to
assess CAT use association with several variables.
Results: 82.16% of individuals who completed the survey declared using CAT at least once in the last
12 months. Self-help practices were the most used CAT category (74.47%), it was followed by herbal
medicine and dietary supplements (62.66%) and visits to CAT providers (41.91%). CAT use was more
prevalent among women, patients with basic education, and patients currently married and widowed.
The most common reason pointed for using CAT was to improve well-being (35.4%). 50.5% of CAT
users declared that they find used therapy helpful or very helpful. The study revealed an exceptionally
high prevalence of spiritual practices (self-prayer, spiritual healing) in comparison to previous European
studies conducted among the cancer patient population.
Conclusions: The study indicated that usage of CAT among advanced cancer patients treated at home
is significant, with a higher prevalence of spiritual practices than reported in previous studies among
cancer patients in Europe.

Article available in PDF format

View PDF Download PDF file

References

  1. Mongiovi J, Shi Z, Greenlee H. Complementary and alternative medicine use and absenteeism among individuals with chronic disease. BMC Complement Altern Med. 2016; 16: 248.
  2. Kuo YH, Tsay SL, Chang CC, et al. Cancer Impact, Complementary/Alternative Medicine Beliefs, and Quality of Life in Cancer Patients. J Altern Complement Med. 2018; 24(3): 276–281.
  3. Quandt SA, Verhoef MJ, Arcury TA, et al. Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q). J Altern Complement Med. 2009; 15(4): 331–339.
  4. Eardley S, Bishop FL, Cardini F, et al. A pilot feasibility study of a questionnaire to determine European Union-wide CAM use. Forsch Komplementmed. 2012; 19(6): 302–310.
  5. Re MLo, Schmidt S, Güthlin C. Translation and adaptation of an international questionnaire to measure usage of complementary and alternative medicine (I-CAM-G). BMC Complement Altern Med. 2012; 12: 259.
  6. Wemrell M, Merlo J, Mulinari S, et al. Two-Thirds of Survey Respondents in Southern Sweden Used Complementary or Alternative Medicine in 2015. Complement Med Res. 2017; 24(5): 302–309.
  7. Johnson C, Aaronson N, Blazeby JM; Guidelines for Developing Questionnaire Modules, on behalf of the EORTC Quality of Life Group: EORTC Quality of Life Group Translation Procedure. EORTC, 4th edition; April 2011. www.eortc.org (October 10, 2018).
  8. Bozza C, Gerratana L, Basile D, et al. Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study : Complementary and alternative medicine in oncology. J Cancer Res Clin Oncol. 2018; 144(10): 2029–2047.
  9. Abdallah R, Xiong Y, Lancaster JM, et al. Complementary and Alternative Medicine Use in Women With Gynecologic Malignancy Presenting for Care at a Comprehensive Cancer Center. Int J Gynecol Cancer. 2015; 25(9): 1724–1730.
  10. Edwards GV, Aherne NJ, Horsley PJ, et al. Prevalence of complementary and alternative therapy use by cancer patients undergoing radiation therapy. Asia Pac J Clin Oncol. 2014; 10(4): 346–353.
  11. Bosacki C, Vallard A, Gras M, et al. Complementary and alternative medicines in cancer patients. Bull Cancer. 2019; 106(5): 479–491.
  12. Abuelgasim KA, Alsharhan Y, Alenzi T, et al. The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia. BMC Complement Altern Med. 2018; 18(1): 88.
  13. Lee JuAh, Sasaki Y, Arai I, et al. An assessment of the use of complementary and alternative medicine by Korean people using an adapted version of the standardized international questionnaire (I-CAM-QK): a cross-sectional study of an internet survey. BMC Complement Altern Med. 2018; 18(1): 238.
  14. Kristoffersen AE, Stub T, Broderstad AR, et al. Use of traditional and complementary medicine among Norwegian cancer patients in the seventh survey of the Tromsø study. BMC Complement Altern Med. 2019; 19(1): 341.
  15. Wode K, Henriksson R, Sharp L, et al. Cancer patients' use of complementary and alternative medicine in Sweden: a cross-sectional study. BMC Complement Altern Med. 2019; 19(1): 62.
  16. Mesquita AC, Chaves Éd, Barros GA. Spiritual needs of patients with cancer in palliative care: an integrative review. Curr Opin Support Palliat Care. 2017; 11(4): 334–340.
  17. Van Hyfte GJ, Kozak LE, Lepore M. A survey of the use of complementary and alternative medicine in Illinois hospice and palliative care organizations. Am J Hosp Palliat Care. 2014; 31(5): 553–561.
  18. Zeng YS, Wang C, Ward KE, et al. Complementary and Alternative Medicine in Hospice and Palliative Care: A Systematic Review. J Pain Symptom Manage. 2018; 56(5): 781–794.e4.
  19. Abdullah N, Borhanuddin B, Patah AE, et al. Utilization of Complementary and Alternative Medicine in Multiethnic Population: The Malaysian Cohort Study. J Evid Based Integr Med. 2018; 23: 2515690X18765945.
  20. Ganguly S, Chandra A, Chatterjee IB. Pathobiology of cigarette smoke-induced invasive cancer of the renal pelvis and its prevention by vitamin C. Toxicol Rep. 2018; 5: 1002–1010.
  21. Ravindranathan P, Pasham D, Balaji U, et al. A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer. Sci Rep. 2018; 8(1): 13869.



Palliative Medicine in Practice